Share Price | Aptus Pharma Ltd Stock Analysis & Recommendation

Q: Why is Aptus Pharma Ltd falling/rising?

As of 08-May, Aptus Pharma Ltd's stock price is falling, currently at 425.00, which represents a decrease of 20.0 points or 4.49%. This decline follows a trend reversal after nine consecutive days of gains, indicating a significant shift in market sentiment. Additionally, the stock has underperformed its sector by 4.45% today, suggesting that it is not keeping pace with broader market movements.The stock also touched an intraday low of Rs 423.5, reflecting a drop of 4.83% during the trading session. Furthermore, there has been a notable decrease in investor participation, with delivery volume dropping by 57.14% compared to the 5-day average, which may indicate reduced interest from investors. Despite these negative indicators, it is worth noting that Aptus Pharma is still trading above its moving averages across various time frames, which could suggest underlying strength. However, the current data points to a clear downward movement in the stock price.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

10.0 k (8.70%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

72.89%

What is the bonus history of Aptus Pharma?

30-Apr-2026

Aptus Pharma recently announced a 3:2 bonus issue, with an ex-date of May 12, 2026. Shareholders on record by this date will receive 3 additional shares for every 2 shares they currently hold.

View full answer

Why is Aptus Pharma Ltd falling/rising?

09-May-2026

As of 08-May, Aptus Pharma Ltd's stock price is declining, currently at 425.00, down 4.49% after a trend reversal following nine days of gains. The stock has underperformed its sector and experienced a significant drop in investor participation, indicating reduced interest.

View full answer

Which are the latest news on Aptus Pharma?

09-May-2026

What is the bonus history of Aptus Pharma?

Compare Aptus Pharma with Similar Stocks

Sat Kartar Trident Lifeline Infinium Pharma

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 305 Cr (Micro Cap)

P/E

98.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.28

Return on Equity

13.64%

Price to Book

14.07

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

72.27%

6 Months

192.1%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Aptus Pharma for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

What is the bonus history of Aptus Pharma?

Aptus Pharma has a recent bonus issue where they announced a 3:2 bonus. The ex-date for this bonus is set for May 12, 2026. This means that shareholders on record as of this date will receive additional shares in the ratio of 3 shares for every 2 shares they currently hold....

Read full news article

Announcements

Announcement under Regulation 30 (LODR)-Press Release / Media Release

28-Apr-2026 | Source : BSE

Press release on Financial Results for the Half Year and Year ended on 31st March 2026.

Statement Of Deviation(S) Or Variation(S) In Utilization Of Proceeds Of Initial Public Offer Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

28-Apr-2026 | Source : BSE

Statement of Deviation(s) or Variation(s) in utilization of proceeds of initial Public Offer pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Audited Financial Results For The Half Year And Year Ended On 31St March 2026

27-Apr-2026 | Source : BSE

Audited Financial Results for the half Year and Year ended on 31st March 2026.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

Aptus Pharma Ltd has announced 3:2 bonus issue, ex-date: 12 May 26

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

2.91

Debt to EBITDA (avg)

1.71

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.82

Tax Ratio

27.80%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

28.87%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

13.44

EV to EBIT

63.56

EV to EBITDA

60.08

EV to Capital Employed

18.35

EV to Sales

11.62

PEG Ratio

Dividend Yield

ROCE (Latest)

28.87%

ROE (Latest)

13.64%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

Bearish

Bollinger Bands

Bullish

KST

Dow Theory

Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Kapilbhai Hasmukhbhai Chandarana (11.3%)

Highest Public shareholder

Saint Capital Fund (4.29%)

Individual Investors Holdings

23.47%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Aptus Pharma"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.38",
          "val2": "9.76",
          "chgp": "47.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.93",
          "val2": "1.98",
          "chgp": "47.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.43",
          "val2": "0.11",
          "chgp": "290.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.75",
          "val2": "1.31",
          "chgp": "33.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.38%",
          "val2": "20.29%",
          "chgp": "0.09%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Aptus Pharma"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24.56",
          "val2": "17.86",
          "chgp": "37.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.75",
          "val2": "1.54",
          "chgp": "208.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.47",
          "val2": "0.24",
          "chgp": "95.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.96",
          "val2": "0.80",
          "chgp": "270.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.34%",
          "val2": "8.62%",
          "chgp": "10.72%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

14.38

9.76

47.34%

Operating Profit (PBDIT) excl Other Income

2.93

1.98

47.98%

Interest

0.43

0.11

290.91%

Exceptional Items

0.00

Standalone Net Profit

1.75

1.31

33.59%

Operating Profit Margin (Excl OI)

20.38%

20.29%

0.09%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

24.56

17.86

37.51%

Operating Profit (PBDIT) excl Other Income

4.75

1.54

208.44%

Interest

0.47

0.24

95.83%

Exceptional Items

0.00

Standalone Net Profit

2.96

0.80

270.00%

Operating Profit Margin (Excl OI)

19.34%

8.62%

10.72%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Aptus Pharma Ltd

Aptus Pharma Ltd

Micro Cap

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available